Therapy Areas: Oncology
Coiled Therapeutics reports enhanced efficacy for AO-252 and accelerates transition to dose expansion
8 April 2026 - Oncology company Coiled Therapeutics plc (AIM: COIL) reported on Monday that it has recorded improved clinical outcomes from its ongoing Phase I/II trial (NCT06136884) of AO-252, suppor...
IDEOlogy Health and West Cancer Center partner to advance patient-centred oncology education and care
8 April 2026 - IDEOlogy Health, a provider of non-promotional, multi-channel medical education to oncology professionals, on Tuesday announced two exclusive strategic partnership agreements with West ...
Gilead to acquire Tubulis to expand ADC oncology capabilities
7 April 2026 - US biopharmaceutical company Gilead Sciences Inc (Nasdaq:GILD) announced on Tuesday that it has entered into a definitive agreement to acquire Tubulis GmbH, a German clinical-stage biot...
FDA grants Fast Track status to SIM0505 for platinum‑resistant ovarian cancer
...
Akeso reports updated data on cadonilimab combination therapy in PD-(L)1 inhibitor-resistant advanced NSCLC data
7 April 2026 - Chinese biopharmaceutical company Akeso Inc (HK:9926) said on Monday that, at the 2026 European Lung Cancer Congress (ELCC 2026), it reported updated results with a median follow-up of ...
AstraZeneca reports positive Phase III data for Imfinzi and Imjudo in liver cancer
...